Telomir Pharmaceuticals, Inc. Common Stock (TELO) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Telomir Pharmaceuticals, Inc. Common Stock (TELO) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

TELO Cash Flow Statement

Telomir Pharmaceuticals, Inc. Common Stock (TELO) cash flow statement — 5-year operating, investing & financing cash flows

Annual Quarterly

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q1'22

Cash from Operations	-1.01M	-1.77M	-1.2M	-927.26K	-696.45K	-863.13K	-605.81K	-1M	-1.52M	-1.94M	-1.09M	-2M	-33.58K	-735.74K	-255.79K	0
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-45.36%	-105.47%	-98.3%	7.49%	54.27%	55.5%	44.28%	49.96%	-4435.38%	-163.6%	-325.04%	-	-	-	-	-
Net Income	-1.72M	-990.95K	-2.06M	-1.1M	-5.07M	-2.18M	-2.9M	-5.93M	-1.45M	-6.25M	-9.33M	-1.71M	-1.55M	-482.94K	-487.1K	-63.49K
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	238.54K	0	0	-741.86K	4.66M	1.38M	2.06M	4.81M	0	0	0	0	0	0	0	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	547.93K	39.8K	-7.95K	840K	-1	-28.68K	130K	0	0	4.34M	8.22M	757.17K	124.05K	0	0	63.49K
Working Capital Changes	-77.28K	-822.37K	867.79K	76.89K	-291K	-30.32K	100.53K	123.13K	-73.84K	-23.35K	23K	-1.05M	1.39M	-252.8K	231.31K	0
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	-84.09K	-257.15K	207.39K	0	0	0	81.06K	0	0	74.74K	22.75K	-1.05M	0	0	0	0
Cash from Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	622.11K	47.35K	1.16M	7.5M	1.05M	0	1.04M	-46.91K	132.44K	5.21M	1.09M	1.99M	46.4K	736.13K	250.88K	0
Debt Issued (Net)	0	0	0	0	0	0	0	-132.44K	132.44K	-101K	1.83M	1.56M	487.91K	0	0	0
Equity Issued (Net)	1.01M	0	1M	7.5M	1.05M	0	1.04M	0	0	5.83M	90K	0	-90K	1M	55K	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-384.2K	47.35K	155.52K	0	0	0	1	85.53K	0	-519.48K	-836.08K	429.81K	-351.51K	-263.87K	195.88K	0
Net Change in Cash	-390.23K	-1.73M	-42.63K	6.57M	351.32K	-863.13K	431.49K	-1.05M	-1.39M	3.27M	-1.22K	-12.18K	12.82K	388	-4.91K	0
Free Cash Flow	-1.01M	-1.77M	-1.2M	-927.26K	-696.45K	-863.13K	-605.81K	-1M	-1.52M	-1.94M	-1.09M	-2M	-33.58K	-735.74K	-255.79K	0
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-45.36%	-105.47%	-98.3%	7.49%	54.27%	55.5%	44.28%	49.96%	-4435.38%	-163.6%	-325.04%	-	-	-	-	-
FCF per Share	-0.03	-0.05	-0.03	-0.03	-0.02	-0.03	-0.02	-0.03	-0.05	-0.07	-0.04	-0.07	-0.00	-0.02	-0.01	-
FCF Conversion (FCF/Net Income)	0.59x	1.79x	0.58x	0.84x	0.14x	0.40x	0.21x	0.17x	1.05x	0.31x	0.12x	1.17x	0.02x	1.52x	0.53x	-
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0